ArticleFrontiers in pharmacology2024

Erratum: Comparison of bleeding risk and hypofibrinogenemia-associated risk factors between tigecycline with cefoperazone/sulbactam therapy and other tigecycline-based combination therapies.

Frontiers Production OfficePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.